Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 156 results found. Search for [ Adar Poonawalla coronavirus vaccine ]

Results 60 to 80 of 156
Rashi Bisaria
New Delhi, September 28, 2020
COVID-19 pandemic: One in every 250 people on Earth now infectedWith total cases standing at 32.4 million or 0.4 per cent of the world's population, every 250th person on the Earth is now infected with coronavirus. As of September 2020, the world's population stood at 7.8 billion, according to the estimates by the United Nations.The total number of deaths now stand at 983,000.Serum Institute shares, applauds PM Modi's vision: Adar Poonawalla on India's vaccine offer to worldA day after Pr...


BusinessToday.In
September 28, 2020
The government is going to assess efficacy data of all concerned companies (working on COVID-19 vaccines) before inking a purchase contract with them and will buy vaccines at least for essential workers


BusinessToday.In
September 27, 2020
Flipkart claims that it will offer the 'biggest offers on smartphones' including mobile protection for just Re 1 among other offers


BusinessToday.In
September 27, 2020
One can stop receiving messages, calls and status updates from certain people by blocking them


BusinessToday.In
September 27, 2020
Padukone accepted that she had sent those messages to her then-manager Karishma Prakash from a WhatsApp group but refused consumption or supply of any narcotics substance to anyone else. The actor used words like - maal, hash, weed - in her chat


BusinessToday.In
September 27, 2020
Adar Poonawalla had earlier expressed concerns around production and distribution plans of the coronavirus vaccine. He asked if the Centre had Rs 80,000 crore available with it over next one year to distribute vaccine to Indians


BusinessToday.In
September 26, 2020
Adar Poonawalla, CEO of the Serum Institute of India (SII), on Saturday expressed his concerns around production and distribution of coronavirus vaccine in the country


BusinessToday.In
September 24, 2020
Bill Gates says India did some \"incredible things\" in terms of using digital infrastructure to transfer money to poor people; says the year 2020 has been an eye-opening year for him as he got time to do \"much more\"


BusinessToday.In
New Delhi, September 23, 2020
Adar Poonawalla is the CEO of his family-owned company Serum Institute of India, which is the world's largest manufacturer of vaccines by volume. Poonawalla, who is in the spotlight in the global vaccine race for coronavirus, has promised to manufacture 400 million doses per month after the approval of the coronavirus vaccine. He has become the biggest hope for the global community during the pandemic. Serum Institute is currently conducting phase 3 clinical trials for the Oxford University-AstraZeneca vaccine. Here is all you need to know about the man himself and how he might prove to be our best bet during the pandemic. Watch the video for more.Also Read: Serum Institute to conduct clinical trials for Novavax COVID-19 vaccine


Reuters
September 18, 2020
In recent weeks, Pfizer has said it should know by the end of October whether the vaccine, developed together with Germany's BioNTech SE, is safe and effective


BusinessToday.In
September 17, 2020
Adar Poonawalla-helmed Serum Institute had partnered with Novavax in August for the production of its coronavirus vaccine. The US drug developer plans to manufacture 2 billion doses annually


BusinessToday.In
September 16, 2020
Coronavirus vaccine trials: While China has four vaccine candidates in third or final stages of clinical trials, there are at least two companies from the United States and one from UK and Germany, which are planning to rollout vaccine before December, if everything goes as per the plan


BusinessToday.In
New Delhi, September 16, 2020
COVID-19 to become seasonal? Herd immunity will decide frequency of outbreak, claims studyScientists have predicted that coronavirus will become a seasonal virus in countries with temperate climates only when herd humanity is attained. Until then, public health measures must be followed to curb the spread of the virus, a review published in Frontiers highlighted. Dr Hassan Zaraket of the American University of Beirut in Lebanon, added, \"COVID-19 is here to stay and it will continue to cause...


Reuters
September 16, 2020
In August, Novavax signed a deal with Serum Institute, the world's largest producer of vaccines, to produce a minimum of one billion doses of its vaccine candidate, when approved, for low- and middle-income countries and India


BusinessToday.In
September 15, 2020
COVID-19 vaccine candidates being developed by Cadila Healthcare and Bharat Biotech have completed the phase one of the study while Pune-based Serum Institute of India (SII) will begin with Phase 3 clinical trial after getting regulatory nod, says ICMR chief


BusinessToday.In
September 15, 2020
Where the UK has resumed the clinical tests of AstraZeneca's COVID-19 vaccine candidate following a review by the country's drug regulator and an independent safety review committee, trials paused in India, US, and South Africa are yet to resume


BusinessToday.In
September 15, 2020
In India, the Bill and Melinda Gates Foundation has partnered with Serum Institute to ramp up the manufacturing and delivery of coronavirus vaccines


BusinessToday.In
September 15, 2020
The head of the world's largest vaccine manufacturer said that the world will need 15 billion doses of the COVID-19 shot if it is a two-dose vaccine


Reuters
September 15, 2020
Enrollment in AstraZeneca's global trials of the vaccine, which it is developing with researchers at Oxford University, was put on pause on September 6


BusinessToday.In
September 13, 2020
Union Health Minister Harsh Vardhan on Sunday said that he will be the first person to take COVID-19 vaccine so as to dispel the \"trust deficit\" around the same


PAGES 4 OF 8  12345